Category: Vascular

Posted on

Prospective untreated outcomes in patients with cerebral cavernous malformation

J Neurosurg 144:1344–1352, 2026

This prospective cohort study quantifies long-term functional outcomes in 332 untreated patients with cerebral cavernous malformation (CCM), using modified Rankin Scale (mRS) scores to evaluate disability over a mean 6.6-year follow-up. It reports incidence of symptomatic hemorrhage (SH), temporal patterns of recovery after a first SH, and external validation of published predictive nomograms.

Key findings identify brainstem location, a history of self-reported psychiatric disorder, and two or more SHs as independent predictors of long-term disability; most patients improved within one year after a first hemorrhage, and ten-year disability risk for nonbrainstem CCM was under 8%.

Objective Elucidate long-term morbidity and disability risk in adults with untreated cerebral cavernous malformation (CCM).

Methods Prospectively followed registry cohort; functional outcome tracked using mRS, with disability defined as mRS ≥ 3; time-to-disability analyzed via Kaplan–Meier and risk factors via Cox models; previously published morbidity nomograms were externally validated.

Cohort 332 patients (58.4% female; mean age 44.5); 19.8% familial CCM; 28.0% brainstem location; 38.3% presented with symptomatic hemorrhage (SH).

Recovery after first SH Among patients with SH who had no further SH and no surgery (n=48), disability (mRS ≥ 3) was 27.1% at diagnosis, improving to 6.2% at 1 year and 4.7% at 5 years, with most improvement in year 1.

Hemorrhage burden Over mean 6.6 years, 31.0% had ≥1 prospective SH and 14.5% had multiple prospective SHs; disability rose sharply with each SH (mRS ≥ 3: 2.3% with 0 SH up to 100% after 5 SHs in untreated follow-up).

Location risk Brainstem CCM carried substantially higher disability risk (18.8% at 5 years; 35.4% at 10 years) versus nonbrainstem locations (4.1% at 5 years; 7.5% at 10 years).

Predictors Multivariate predictors of disability included brainstem location, self-reported psychiatric disorder, and ≥2 SHs.

Nomogram validation Prior nomograms showed high specificity but limited sensitivity; AUC 0.687 for predicting mRS ≥ 2 and 0.783 for predicting mRS ≥ 3.

Posted on

Basilar artery perforator rupture as the cause of perimesencephalic subarachnoid hemorrhage

J Neurosurg 144:1271–1277, 2026

This clinical study evaluates the etiology of perimesencephalic subarachnoid hemorrhage (pmSAH) by applying high-resolution cone-beam CT (CBCT) during catheter angiography to detect basilar artery perforator outpouchings. The retrospective analysis of 22 pmSAH patients found that CBCT identified basilar perforator pseudoaneurysms in a substantial subset, with conservative management yielding excellent outcomes.

The authors argue that many pmSAHs may be arterial rather than venous in origin when imaged with modern high-resolution CBCT protocols. They recommend heightened suspicion for an arterial source and detailed angiographic CBCT acquisition, while acknowledging limits of retrospective design, variable imaging quality, and unresolved management questions.

Objective High-resolution CBCT performed during catheter angiography was used to better identify the etiology of perimesencephalic SAH (pmSAH), challenging the historical assumption of a venous source.

Methods Retrospective review of pmSAH cases (Jan 2023–Dec 2024) requiring catheter angiography with available, diagnostic-quality CBCT; images were interpreted by two experienced neuroangiographers to consensus.

Cohort Of 152 spontaneous SAH presentations, 22 met Rinkel criteria for pmSAH; after exclusions (alternative causes found, missing/low-quality CBCT), 13 patients remained for CBCT-based imaging analysis.

Key finding In 8/13 (61.5%) analyzed pmSAH cases, CBCT showed a basilar artery perforator focal outpouching consistent with a rupture site (submillimeter, 0.4–0.8 mm).

Anatomy distribution Among the 8 identified perforator lesions, 6 were rostral basilar perforators, with 1 midbasilar and 1 caudal perforator involvement.

Outcomes All pmSAH patients—including those with identified basilar perforator outpouchings—had excellent recovery, with no re-rupture events and no clinically significant vasospasm reported in the series.

Follow-up imaging In patients who underwent follow-up DSA with CBCT, the basilar perforator finding resolved on follow-up imaging.

Conclusion/implication pmSAH should be approached with high suspicion for an arterial etiology (basilar perforator pseudoaneurysm frequently detectable with high-resolution CBCT), and conservative management was associated with excellent outcomes in this cohort.

Posted on

A 7-Year Experience in Microsurgical Treatment of Unruptured Intracranial Aneurysms in Older Patients

Neurosurgery 98:1325–1338, 2026

This article reports a 7-year single-center retrospective analysis comparing one-year neurological outcomes after microsurgical clipping of unruptured intracranial aneurysms in patients >65 years versus younger adults. It details patient selection, aneurysm characteristics, statistical methods, and primary endpoint assessment using the modified Rankin Scale.

Findings indicate similar favorable 1-year outcomes between older and younger cohorts, with diabetes and de novo aneurysm formation/growth identified as independent predictors of poor outcome in the older group. The discussion contextualizes results against endovascular options, comorbidity considerations, and limitations of retrospective single-center data.

Question addressed Whether to treat unruptured intracranial aneurysms (UIAs) in patients >65 remains controversial because of frailty/comorbidities and procedural risk vs rupture risk under conservative management.

Study design Retrospective review of UIA patients treated with microsurgical clipping (single quaternary center, 2014–2020), including only those with admission mRS ≤2; primary endpoint was 1-year mRS, with poor outcome defined as mRS >2.

Cohort 390 total surgically treated patients; 132 (34%) were >65 with mean age 71±4 years.

Main outcome No significant difference in poor neurological outcome at 1 year between older vs younger patients (11% vs 9.3%, P=.82), indicating comparable functional outcomes after microsurgery in selected older adults.

Aneurysm differences with age Older patients had larger aneurysm dimensions and more calcification (e.g., calcification 15% vs 2.8%) and higher PHASES/ELAPSS scores than younger patients.

Univariate risk factors (older group) Factors associated with poor 1-year outcome included diabetes, higher Charlson Comorbidity Index, calcification, treating multiple aneurysms, de novo formation/growth, and higher aspect ratio.

Independent predictors On multivariable analysis in older patients, only diabetes (OR 19.1, P=.02) and de novo formation or growth (OR 12.7, P=.02) predicted poor neurological outcome.

Clinical implication Chronological age alone is not a stand-alone contraindication to microsurgical treatment; individualized selection and comorbidity/risk stratification (notably diabetes and aneurysm growth patterns) are key.

Posted on

Clinical Outcomes of Subarachnoid Hemorrhage in Patients With Nicotine Dependence

Neurosurgery 98:1095–1102, 2026

This retrospective, population-based study analyzes clinical outcomes after nontraumatic subarachnoid hemorrhage (SAH) among 43,315 patients with documented nicotine dependence versus patients without substance use disorders. Using the TriNetX network with propensity score matching, primary endpoints included mortality, vasospasm, hydrocephalus, and delayed cerebral ischemia (DCI), with nicotine dependence associated with significantly higher hazards for all outcomes.

The manuscript details methods, matching variables, statistical analyses, mechanistic discussion of nicotine’s vascular effects, and limitations inherent to large electronic health record databases. Conclusions emphasize that nicotine dependence predicts worse SAH outcomes and support prioritizing smoking cessation counseling as part of long-term patient management.

Study focus: Clinical outcomes after nontraumatic subarachnoid hemorrhage (SAH) in adults with nicotine dependence versus those with no substance use disorder diagnoses.

Data source & cohort: TriNetX electronic medical record network analysis of adults (≥18) with ICD-10 I60 (nontraumatic SAH) from 2004–2024; 43,315 had nicotine dependence (F17) out of ~210k+ SAH patients.

Methods: Used 1:1 propensity score matching to balance demographics, comorbidities, lab/substance testing, and SAH severity (NIS-SAH Severity Score elements), then applied Cox proportional hazards and Kaplan–Meier survival analyses.

Mortality risk: Nicotine dependence associated with higher post-SAH mortality hazard (HR ≈ 1.24–1.25, statistically significant).

Vasospasm risk: Nicotine dependence associated with higher hazard of vasospasm (HR ≈ 1.47–1.49, statistically significant).

DCI risk: Nicotine dependence associated with higher hazard of delayed cerebral ischemia (DCI) (HR reported ≈ 1.30–1.35, statistically significant).

Hydrocephalus risk: Nicotine dependence associated with higher hazard of newly diagnosed hydrocephalus (HR ≈ 1.27, statistically significant).

Clinical implication: Elevated risks linked to nicotine dependence underscore the importance of smoking cessation counseling for long-term management after SAH.

Posted on

Chronic Oculomotor Nerve Palsy Presentation From Posterior Communicating Artery Aneurysm

Operative Neurosurgery 30:703–710, 2026

This case series analyzes 17 patients with subacute to chronic oculomotor nerve palsy (ONP) caused by posterior communicating artery (PCoA) aneurysms treated between 1991 and 2024. Demographics, aneurysm characteristics, treatment modalities (clipping vs endovascular), and follow-up outcomes are reported, highlighting that only a minority presented with rupture.

The report finds that complete ONP recovery occurred exclusively in patients treated within five weeks of symptom onset, supporting early definitive management to maximize functional nerve recovery despite chronic ONP not reliably predicting imminent aneurysm rupture.

Clinical question: The natural history of chronic oculomotor nerve palsy (ONP) from posterior communicating artery (PCoA) aneurysm is unclear, especially regarding rupture risk and likelihood of nerve recovery when symptoms persist beyond 1 week.

Cohort & design: Case series from a prospectively accrued institutional database (1991–2024) including patients with ≥1 week ONP attributed to PCoA aneurysm; patients with <1 week onset, inadequate follow-up, or other causes of ONP were excluded.

Patient profile: 17 patients; predominantly female (94.1%), median age 56; ONP duration ranged 1 week to 10 years; 29.4% presented with aneurysm rupture.

Treatment approaches: Most were treated with microsurgical clipping (64.7%) or endovascular therapy (29.4%); one patient was managed conservatively due to comorbidities/limited life expectancy.

ONP recovery outcomes: Complete ONP recovery occurred in 23.5% (4/17); all complete recoveries were in patients with symptom duration <5 weeks.

Timing signal: Subacute ONP (<5 weeks) was associated with better recovery (including complete recovery), while chronic ONP (≥5 weeks) had no complete recoveries in this cohort.

Rupture implication: Chronic ONP appeared not to indicate imminent rupture, with only about one-third presenting ruptured and an example of 10 years of stable ONP preceding rupture in the longest-duration case.

Management takeaway: Even if chronic ONP may not predict near-term rupture, early definitive aneurysm treatment is still recommended to maximize the chance of functional ONP recovery.

Posted on

The role of surveillance MRI scans in patients with sporadic cerebral cavernous malformations

J Neurosurg 144:1017–1023, 2026

This clinical study assesses the diagnostic value of routine versus symptom-driven MRI follow-up in patients with sporadic cerebral cavernous malformations (CCMs), analyzing radiographic changes at the first postdiagnosis scan in a prospective single-center cohort. Results show that new or worsening focal neurological deficit (FND) strongly predicts symptomatic hemorrhage, while routine surveillance rarely detects acute hemorrhage.

Imaging progression—including lesion growth, Zabramski classification changes, T1 hyperintensity, and edema—occurred across indications but had limited impact on management when patients were asymptomatic. The authors recommend symptom-driven MRI, reserving routine surveillance for select cases and early posthemorrhage confirmation.

Objective Evaluate whether routine surveillance MRI vs symptom-driven MRI better detects hemorrhage in patients with sporadic, brain-only cerebral cavernous malformations (CCMs), and what radiographic changes appear at first follow-up.

Cohort/Design Prospective single-center registry analysis of 236 sporadic brain-only CCM patients who had ≥1 follow-up MRI after diagnosis; MRI indications categorized as routine vs symptom-driven (e.g., new/worsening focal neurological deficit [FND], headache, seizure).

Hemorrhage yield Radiographic hemorrhage at first follow-up occurred in 19.1% (13/68) of symptom-driven MRIs vs 1.2% (2/168) of routine/non–CCM-related surveillance MRIs.

Routine progression In routine/non–CCM-related surveillance (n=168), 10.1% showed radiologic progression (growth ≥3 mm, more aggressive Zabramski type, or hemorrhage), but acute hemorrhage was only 1.2%; 88.2% of progression events occurred within 2 years.

Imaging correlates of SH Symptomatic hemorrhage (SH) was associated with lesion growth, moderate-to-severe T1-hyperintensity, and edema at follow-up; baseline lesion size and location did not predict hemorrhage.

Symptom predictors New or worsening FND predicted hemorrhage, while seizure or headache alone did not; in multivariate analysis, only new/worsening FND remained independently associated with hemorrhage (OR 13.73, p<0.001).

Clinical implication Follow-up MRI is most justified when there is new or worsening FND; routine surveillance in asymptomatic patients has limited diagnostic yield but may be reasonable in select situations.

Special cases MRI may still be considered for atypical, prolonged headaches distinct from baseline and not responsive to over-the-counter medication, or for changing/new seizure patterns based on clinical judgment.

Posted on

Microsurgery Versus Embolization for Spinal Cord Arteriovenous Malformations: A Proposed Grading System

Neurosurgery 98:786–798, 2026

This study proposes a four-parameter grading system to stratify angioarchitectural complexity of spinal cord arteriovenous malformations (SCAVMs) and compares clinical outcomes of microsurgery versus endovascular embolization across five grades in a 714-patient multicenter cohort. The grade sums points for metameric manifestation, lesion diameter ≥2 cm, anterior sulcal artery supply, and lesion depth, predicting incomplete resection with strong ROC (receiver-operating characteristic) performance.

Results show embolization as the preferred primary treatment owing to lower immediate risk, while microsurgery achieves higher complete obliteration for low-grade lesions (scores 0–1) but carries greater treatment-related deterioration and worse long-term prognosis for higher grades (scores 2–4). Recommendations prioritize embolization, reserving microsurgery for select low-grade or high-risk patients when embolization fails.

Study aim Compare outcomes of microsurgery vs endovascular embolization for SCAVMs by introducing a grading system that stratifies angioarchitectural complexity to enable fairer comparisons.

Cohort & design Retrospective multicenter analysis of 714 SCAVM patients treated (2007–2022); 308 received microsurgery (often after failed/partial embolization) and 406 received exclusive embolization.

Grading system (0–4 points) One point each for anterior sulcal artery supply, metameric manifestations, maximum lesion diameter ≥2 cm, and embedded (deep) lesion depth; total score defines grade.

Predictors basis & performance The four grading variables were independent predictors of incomplete resection in microsurgical cases, and the score showed strong ROC discrimination in modeling and validation groups (AUC ≈ 0.83).

Overall treatment tradeoff Microsurgery achieved a higher complete obliteration rate (61.7% vs 24.4%) but had higher treatment-related deterioration (19.8% vs 4.2%) and higher poor prognosis at last follow-up (52.3% vs 36.2%) than exclusive embolization.

Low grades (0–2) obliteration For scores 0–2, microsurgery produced significantly higher complete obliteration than embolization; for scores 3–4, complete obliteration rates were similar between methods.

Long-term deterioration & prognosis by grade Long-term clinical deterioration after embolization was higher for score 1 (significant) and also higher for score 0 (not significant); for scores 2–4, long-term deterioration risk was comparable, while poor prognosis was generally worse with microsurgery except score 0 (similar).

Treatment strategy Embolization should be the primary approach for SCAVMs; microsurgery is an alternative if embolization fails to fully obliterate lesions in score 0 (recommended) and selected 1-point patients (optional, especially higher clinical risk), but not first-line for scores 2–4.

Posted on

Treatment strategies, complications, and outcomes in spontaneous cerebellar hemorrhage

Acta Neurochirurgica (2026) 168:99

This single-center observational study examines treatment strategies, complications, and outcomes in 194 adults with spontaneous cerebellar hemorrhage (sCH) managed at a Swedish neurointensive care unit between 2008–2024. It compares conservative care, external ventricular drainage (EVD) alone, and combined hematoma evacuation with suboccipital decompression plus EVD, reporting short- and long-term mortality, functional outcome at discharge, and procedure-related complications.

Key findings show that conservative management often succeeds for neurologically stable patients with moderate hematomas (>15 mL), while combined evacuation/decompression with EVD is safe and effective for more severe presentations; EVD alone can suffice for selected hydrocephalus-predominant cases. Age, admission neurological status (GCS M), and hematoma volume independently predict 6-month mortality and functional outcome.

Study design Retrospective single-center cohort of adults with primary spontaneous cerebellar hemorrhage treated in a neurointensive care unit in Uppsala, Sweden (2008–2024), comparing conservative vs surgical management and analyzing predictors of 6‑month mortality and discharge functional outcome (GODS).

Treatment selection About half of 194 patients underwent surgery; surgically treated patients typically had worse neurological status, larger hematoma volumes, and more posterior fossa mass effect (e.g., fourth ventricle compression/hydrocephalus/IVH).

Conservative strategy for stable moderate-large bleeds In awake/stable patients with hematomas >15 mL initially managed conservatively, 78% did not need delayed surgery and most achieved favorable outcomes.

Surgical approach and safety Combined hematoma evacuation with suboccipital decompression plus EVD was associated with low complication rates and low early mortality in this cohort.

EVD-only option in selected cases Some patients with hydrocephalus and smaller hemorrhages were successfully treated with EVD alone, suggesting this may suffice when hydrocephalus predominates without dominant infratentorial mass effect.

Outcomes Overall mortality was 11% at discharge and 28% at 6 months; discharge outcomes differed by treatment group (higher early mortality but higher favorable discharge outcome in conservatively managed patients), while 6‑month mortality was similar between groups.

Key prognostic factors Age, neurological status (GCS motor score), and hematoma volume independently predicted 6‑month mortality; GCS motor score and hematoma volume independently predicted favorable discharge outcome (GODS > 3).

Clinical implication Favorable outcomes were achievable even in elderly patients; conservative care fit neurologically stable patients with moderate volumes, while surgery/EVD pathways were used for more severe presentations or deterioration.

Posted on

Neuropsychological profile and risk factors for poor cognitive outcomes in survivors of aneurysmal subarachnoid hemorrhage

J Neurosurg 144:517–525, 2026

This clinical study characterizes long-term neuropsychological outcomes in 156 survivors of aneurysmal subarachnoid hemorrhage (aSAH), using MoCA-22, digit span, and verbal fluency tests. Findings show that 34% scored below the 25th percentile despite largely favorable functional recovery, with deficits concentrated in executive function, working memory, and language.

Multivariable analysis identified modified Fisher grade 4 on admission and new radiological infarction during hospitalization as independent predictors of poor cognitive outcomes. Secondary assessments revealed frequent depressive symptoms and acquired personality disturbances, implicating impacts on work productivity and social relationships.

Objective Characterize neuropsychological deficits in aneurysmal subarachnoid hemorrhage (aSAH) survivors and identify clinical variables linked to poor cognitive outcomes.

Design/assessments Retrospective cohort (2009–2024) with cognitive testing ≥6 months post-aSAH using MoCA-22, Digit Span Forward/Backward, and Verbal Fluency; poor outcome defined as MoCA-22 <25th percentile (norm-adjusted).

Prevalence 34% (53/156) had MoCA-22 <25th percentile despite most having good functional recovery at discharge (mRS ≤2 in 79% of those with poor MoCA-22).

Cognitive profile Moderate/severe deficits (z-score >1 SD below norms) occurred in 11% on DST-F, 27% on DST-B, and 9% on VFT, highlighting prominent working-memory/executive-function vulnerability.

Key risk factors Modified Fisher grade 4 on admission and new radiological infarction during hospitalization were independently associated with poor MoCA-22 outcomes (aOR 2.43 and 2.71, respectively).

Quality of life impact Radiological infarction was associated with worse work productivity (OR 0.69) and social relationships (OR 0.72).

Behavioral sequelae Among those assessed, 27% reported at least mild depressive symptoms and 64% showed acquired personality disturbance.

Bottom line Cognitive/behavioral deficits can persist long after aSAH even with favorable mRS; higher hemorrhage burden (modified Fisher 4) and in-hospital infarction signal higher risk.

Posted on

Perimesencephalic hemorrhage: a proposed explanation of its cause and clinical manifestations

J Neurosurg 144:740–746, 2026

This neurosurgical forum article analyzes perimesencephalic hemorrhage (PMH), proposing that small dural arterial variants—particularly the artery of Wollschlaeger and Wollschlaeger (AWW) arising from the superior cerebellar artery—can undergo distraction-avulsion and explain PMH’s characteristic cisternal distribution and benign clinical course. The authors present a surgical case with intraoperative identification of an SCA-derived dural branch and perform detailed anatomical correlation.

The paper contrasts venous and arterial hypotheses, reviews perimesencephalic cisternal anatomy and tentorial blood supply, and argues that spontaneous tearing of a tethered intradural dural branch best accounts for imaging, pathophysiology, and low recurrence of PMH, while acknowledging limits of confirmatory testing.

PMH profile Nonaneurysmal perimesencephalic hemorrhage (PMH) is ~10%–15% of spontaneous cisternal SAH, with CT blood confined around the midbrain and typically a benign course with complete recovery and rare recurrence.

Unknown etiology Despite decades of imaging/anatomical work, the cause often remains unidentified on initial and follow-up angiography, leading to the concept of “SAH of unknown cause,” especially when bleeding is perimesencephalic-only.

Index case A 54-year-old woman with SAH had angiography showing a dural arteriovenous fistula (DAVF) fed by the meningohypophyseal trunk and draining via the superior petrosal vein; surgery disconnected the fistula with good outcome.

Unexpected anatomy Intraoperatively, a dural branch from the superior cerebellar artery (SCA) was found bridging the ambient cistern to the undersurface of the tentorium (the artery of Wollschlaeger and Wollschlaeger, AWW) and was sacrificed; it had not been seen on preop angiography and was not the hemorrhage source in that case.

Key anatomical concept The perimesencephalic cistern system (interpeduncular, ambient, quadrigeminal) surrounds the midbrain at the tentorial incisura; vessels can traverse cisternal spaces and arachnoid septations, influencing where blood can collect.

Tentorial dural supply variants The medial tentorium can be supplied by the marginal tentorial artery from the meningohypophyseal trunk, plus intradural-origin dural branches from the PCA (artery of Davidoff and Schechter, ADS) and from the SCA (AWW) that course within the ambient cistern before entering tentorium.

Competing sources considered Two structures fit many PMH constraints: the basal vein of Rosenthal (BVR) (venous, tethered to vein of Galen) and the ADS/AWW (arterial dural branches tethered to the medial tentorial edge).

Proposed mechanism for PMH Spontaneous distraction-avulsion of the AWW from its fragile tentorial attachment during everyday Valsalva/exertion could cause focal cisternal bleeding that self-limits as pressure equalizes in the confined cistern; this is proposed to explain PMH distribution, negative angiography, generally mild course, low hydrocephalus/vasospasm, and rare rebleed.

Posted on

The Helsinki Unruptured Intracranial Aneurysm Quality of Care study: a prospective observational study

J Neurosurg 144:507–516, 2026

This prospective single-center study evaluates the safety of unruptured intracranial aneurysm (UIA) treatments by prospectively measuring postprocedural diffusion-weighted MRI (DWI) lesions and correlating them with clinical outcomes at 3 months. Among 169 consecutive patients, 63% developed new DWI lesions, with endovascular cases showing more multiple lesions and surgical cases showing larger lesions.

Despite excellent functional outcomes by modified Rankin Scale (98% mRS 0–1) and high return-to-work rates, DWI lesions were associated with increased neurological symptoms, longer hospital stays, and worse outcomes when ≥10 mm. The authors argue that routine DWI should complement mRS to better capture ischemic burden and guide quality assessment and follow-up.

Objective Evaluate safety of unruptured intracranial aneurysm (UIA) treatment by measuring postprocedural ischemic lesions on MRI diffusion-weighted imaging (DWI) and correlating them with clinical outcomes.

Design Prospective, investigator-initiated, single-center observational cohort of consecutive UIA patients treated at Helsinki University Hospital (Dec 2022–Aug 2024) with brain MRI within 3 days and 3-month follow-up (mRS, neurological symptoms, return to work).

Cohort 169 patients: 120 (71%) endovascular and 49 (29%) surgical; aneurysm location distribution differed (most surgical cases were MCA aneurysms).

DWI incidence New DWI lesions occurred in 63% overall, with no difference between endovascular and surgical treatment (63% vs 63%).

Lesion patterns by modality Endovascular treatment more often produced high lesion counts (≥6 lesions: 14% vs 0%), while surgery more often produced larger lesions (≥10 mm: 20% vs 8%).

Symptoms association Most DWI lesions were asymptomatic (85%), but having any DWI lesion increased risk of new neurological symptoms (15% vs 2%), with 59% of symptoms transient.

mRS association Any DWI lesion was not associated with mRS outcomes, but lesions ≥10 mm were linked to poorer mRS status (mRS 0–1: 84% vs 99%) and higher risk of mRS worsening (21% vs 1%).

Return to work & conclusion 97% of previously working patients returned to work within 3 months; DWI lesions are common despite excellent mRS outcomes, and DWI may add information that mRS alone misses when assessing quality of care.

Posted on

Intraoperative Evaluation of Dural Arteriovenous Fistula Obliteration Using FLOW 800 Hemodynamic Analysis

Operative Neurosurgery 30:250–259, 2026

This clinical study evaluates intraoperative indocyanine green videoangiography with FLOW 800 software to quantify hemodynamic changes during cranial and spinal dural arteriovenous fistula (dAVF) microsurgical obliteration. Using four FLOW 800 metrics across venous regions of interest, the authors compare pre- and post-obliteration measurements confirmed by intraoperative digital subtraction angiography.

Key findings identify increased Delay Time and decreased Speed as consistent, significant markers of successful dAVF obliteration, supported by nonparametric tests, logistic and Bayesian regression, and PCA visualization. The study suggests FLOW 800 as a practical adjunct to intraoperative imaging, while acknowledging limitations from small sample size and ROI selection variability.

Key Hemodynamic Parameters: Intraoperative FLOW 800 analysis of indocyanine green videoangiography quantifies four hemodynamic parameters—Delay Time, Speed, Time to Peak, and Rise Time—across venous drainage regions before and after dAVF (dural arteriovenous fistula) obliteration.

Most Sensitive Indicators: Delay Time (time for dye to reach ROI) and Speed (rate of dye flow) are the most sensitive and consistent hemodynamic indicators of successful dAVF obliteration, with Delay Time increasing and Speed decreasing significantly post-obliteration.

Statistical Significance: Delay Time increased from a median of 2.07s to 7.86s (P = .020), and Speed decreased from 13.5 s⁻¹ to 5.5 s⁻¹ (P = .029), both changes being statistically significant; Time to Peak and Rise Time showed no significant association.

Predictive Value: A 50% increase in Delay Time is associated with 2.16 times higher odds of achieving obliteration (OR = 4.59), while a 50% decrease in Speed is associated with 1.28 times higher odds; Delay Time and Speed are the strongest predictors in regression analyses.

Clinical Utility: FLOW 800 provides real-time, semiquantitative intraoperative feedback, supporting its use as a noninvasive adjunct to traditional imaging (like intraoperative DSA) for confirming dAVF obliteration, especially where DSA is unavailable.

Study Limitations: The study is limited by small sample size (8 patients, 14 ROIs), single-center design, and possible variability in ROI selection; findings require validation in larger, multicenter studies.

Practical Considerations: Complete visualization of venous outflow is necessary for FLOW 800 utility; current evidence supports its use as a complementary tool rather than a replacement for DSA.

Clinical Outcome: All patients in the study had successful dAVF obliteration confirmed by intraoperative DSA, no complications or recurrences at median 19.4 months follow-up, and FLOW 800 changes were consistent with successful surgical outcomes.

Posted on

Predicting chronic subdural hematoma risk in elderly patients with mild traumatic brain injury

Acta Neurochirurgica (2026) 168:40

This study develops and validates a concise bedside risk score to predict chronic subdural hematoma (CSDH) within 2–12 weeks after mild traumatic brain injury in patients aged 65+. Using a large retrospective cohort (7,246 events) and multivariable modeling, pathological CT at presentation, male sex, older age, and renal failure emerged as key predictors.

The score-based model (including anticoagulant use by expert choice) achieved AUROC 0.76 and 86% sensitivity at the chosen threshold, classifying ~61% as high-risk. Authors propose this tool to guide targeted surveillance and earlier intervention, while noting limitations from retrospective data and need for external validation.

Pathological CT Findings: Pathological findings on initial head CT after mild traumatic brain injury (TBI) are the strongest predictor for developing chronic subdural hematoma (CSDH) within 2–12 weeks in elderly patients.

Key Risk Factors: Older age, male sex, and renal failure are also significant independent predictors for CSDH following mild TBI.

Anticoagulant Use: Chronic use of anticoagulant medications showed a trend toward increased risk but was not statistically significant in this cohort; antiplatelet use was not associated with increased risk.

Prediction Model: A simple score-based risk model was developed, incorporating pathological CT (14 points), male sex (4), renal failure (4), anticoagulant use (4), and age (1 point per 5 years over 65), with a threshold of 5 points or higher identifying high-risk patients.

Model Performance: The risk model achieved an area under the ROC curve (AUROC) of 0.76 and a sensitivity of 86% for detecting CSDH, but the positive predictive value was low (1.6%) due to the rare occurrence of the outcome.

Clinical Implications: Early identification of high-risk patients may enable targeted surveillance, timely CT scanning, and consideration of non-surgical management options such as corticosteroids or middle meningeal artery embolization.

Population Impact: The incidence of CSDH is rising globally due to population aging and increased use of antithrombotic agents, with elderly adults being particularly at risk.

Study Scope: The findings support the use of bedside risk stratification in the emergency department for elderly patients with mild TBI, but further research is needed before widespread clinical implementation.

Posted on

Impact of Clinical Variables and Aneurysm Morphology on Hemorrhage Volume and Clinical Outcomes

Neurosurgery 98:394–403, 2026

This study investigates determinants of aneurysmal subarachnoid hemorrhage (aSAH) volume and its effect on early clinical outcomes using objective, semiautomated CT quantification in 200 ruptured intracranial aneurysms. Multivariate analysis identified older age, higher Hunt and Hess score, and bifurcation aneurysm location as independent predictors of larger aSAH volume, while sex (female) correlated with lower volumes.

Outcome analysis stratified by age showed that in patients 18–64 years greater aSAH volume increased risk of delayed cerebral ischemia, clinical vasospasm, and 7-day mortality; in patients ≥65 years larger volume was associated only with 7-day mortality. The authors recommend multicenter studies using objective quantification to validate age-specific clinical implications.

Hemorrhage Volume Predictors: Larger aneurysmal subarachnoid hemorrhage (aSAH) volumes are associated with older age, higher Hunt and Hess (HH) scores at admission, and ruptured aneurysms located at arterial bifurcations, especially the basilar tip; women have lower hemorrhage volumes than men.

Aneurysm Morphology: Aneurysm size, aspect ratio (AR), size ratio (SR), and irregular morphology do not significantly influence aSAH volume, although bifurcation location is a strong predictor of increased hemorrhage volume.

Hemodynamics Over Morphology: Hemorrhage volume appears to be more influenced by cerebral flow dynamics and aneurysm location (bifurcation vs. sidewall) than by traditional morphological parameters such as size or shape.

Age-Dependent Outcomes: In patients aged 18–64 years, larger aSAH volume is linked to increased risk of delayed cerebral ischemia (DCI), clinical vasospasm, and 7-day mortality; in patients ≥65 years, larger volume is only associated with increased 7-day mortality, not DCI or vasospasm.

Elderly Population Specifics: Lower risk of vasospasm and DCI in elderly patients may be due to arteriosclerotic changes and larger cisternal spaces, which allow greater blood accumulation without corresponding clinical symptoms.

Objective Measurement: Use of semiautomated, machine learning-based tools (e.g., MATLAB segmentation) provides more reliable and reproducible quantification of hemorrhage volume compared to subjective grading systems.

Clinical Implications: Objective hemorrhage quantification could improve risk stratification, facilitate personalized treatment, and enhance understanding of blood clearance and outcomes after aSAH.

Research Recommendations: Multicenter studies using objective quantification methods are needed for validation and to refine management strategies for ruptured aneurysms, considering age-specific differences

Posted on

Natural History of Sporadic Cerebral Cavernous Malformations by Zabramski Classification: Hemorrhage Risk and Functional Outcomes Over 5 Years

Neurosurgery 98:376–383, 2026

This prospective cohort study examines sporadic cerebral cavernous malformations (CCMs) categorized by Zabramski MRI types I–IV, reporting lesion features, presentation, hemorrhage rates, and mRS outcomes over a mean follow-up of 4.7 years. Type I lesions had the highest symptomatic presentation, largest size, brainstem predominance, and elevated hemorrhage risks.

Functional outcomes improved for some patients, but Type I had the poorest outcomes. Severe symptomatic hemorrhage was the strongest predictor of sustained disability (mRS ≥3). Types III and IV had low hemorrhage rates and favorable prognoses, supporting conservative management and tailored follow-up imaging.

Zabramski Classification: Stratifies cerebral cavernous malformations (CCMs) into Types I–IV based on MRI features, which correlate with clinical presentation, hemorrhage risk, and functional outcomes.

Type I Lesions: Show the highest annual symptomatic hemorrhage (SH) rate (13.9%), a 5-year cumulative risk of 50.6%, are mostly symptomatic at presentation, often located in the brainstem, and have the poorest long-term functional outcomes (mRS ≥2 in 35.4% at last follow-up).

Type II and III Lesions: Exhibit lower annual hemorrhage rates (2.9% and 1.8%, respectively), more frequently present with seizures or focal neurological deficits rather than hemorrhage, and have better long-term functional outcomes (Type II: mRS ≥2 in 11.2%; Type III: mRS ≥2 in 7.5% at last follow-up).

Type IV Lesions: Are exclusively asymptomatic, detected incidentally, have no observed hemorrhagic events during follow-up, and show no functional impairment (no cases of mRS ≥2).

Severe Symptomatic Hemorrhage: Is the strongest independent predictor of poor functional outcome (mRS ≥3), outweighing lesion type, age, location, or surgical intervention in multivariate analysis (HR 10.88, P < .001).

Dynamic Lesion Evolution: Zabramski type can change over time, particularly for Type I lesions, highlighting the need for longitudinal imaging and dynamic risk assessment rather than reliance on a single timepoint classification.

Clinical Management Implications: Conservative management is appropriate for most Type III and IV lesions due to their benign natural history, while Type I lesions require closer monitoring and individualized intervention strategies due to higher risk.

Study Limitations: Small sample sizes for Types III and IV, potential MRI protocol variability, and single-center design may limit generalizability; multicenter studies are needed for broader validation.

Posted on

Single-Session Middle Meningeal Artery Embolization With Concomitant Evacuation Surgery for Chronic Subdural Hematomas: A Multicenter Assessment of Feasibility, Safety, and Efficacy

Operative Neurosurgery 30:270–277, 2026

This multicenter retrospective cohort assesses feasibility, safety, and short-term efficacy of performing middle meningeal artery embolization (MMAE) concurrently with surgical evacuation for chronic subdural hematoma in a single anesthetic session. Among 157 patients, technical success was 97.4%, radiographic improvement occurred in 91.7%, and 63.1% achieved ≥50% hematoma reduction, with a 10.8% overall complication rate and 0.6% procedure-related mortality.

The report compares outcomes to recent randomized trials and existing series, noting similar intraprocedural complication rates and favorable reintervention and functional-independence outcomes (83.9% mRS ≤2 at median 54 days). Authors highlight potential resource and LOS advantages, acknowledge retrospective limitations, and call for prospective studies to define long-term benefit, cost impact, and selection criteria.

Single-session MMAE plus evacuation: Performing middle meningeal artery embolization (MMAE) and surgical evacuation for chronic subdural hematoma (cSDH) in a single anesthetic session is feasible and technically successful in 97.4% of cases, with no major intraprocedural failures reported.

Safety profile: The overall complication rate for the combined procedure is 10.8%, with a low intraprocedural complication rate of 2.5% and a procedure-related mortality of 0.6%, comparable to or better than staged approaches and recent randomized trials.

Radiographic and functional outcomes: Radiographic improvement is observed in 91.7% of patients, with 63.1% achieving at least a 50% reduction in hematoma thickness; 83.9% of patients maintain or achieve functional independence (mRS ≤2) at short-term follow-up.

Hospital length of stay (LOS): The median hospital LOS is 6 days, which is slightly shorter than reported in comparable studies using staged procedures, suggesting potential for reduced resource utilization.

Reintervention rates: Unplanned reoperations during the index hospitalization are low (2.5%), including for recurrent hematomas and subdural empyema, which favorably compares to other large studies and randomized trials.

Patient selection and anesthesia: Most procedures use general anesthesia (92%), but monitored anesthesia care (MAC) or conscious sedation may further streamline care in selected patients and reduce anesthesia-related risks.

Applicability to complex cases: The single-session approach is effective and safe even in patients with bilateral cSDH, who are often considered more complex.

Future directions: Prospective studies are needed to assess long-term outcomes, cost-effectiveness, ideal patient selection, and whether this approach reduces recurrence and enhances recovery compared to staged strategies.

Posted on

Added Value of Adjunctive Middle Meningeal Embolization to Surgical Evacuation for Chronic Subdural Hematoma: Comprehensive Meta-Analysis Based on Controlling Confounders

Neurosurgery 98:303–317, 2026

This meta-analysis evaluates whether adding middle meningeal artery embolization (MMAE) to surgical evacuation improves outcomes in patients with chronic subdural hematoma (CSDH).

Key Insights and Themes

Chronic subdural hematoma (CSDH) is a common neurological disorder with high recurrence rates after surgical evacuation, ranging from 2% to 37%.

Middle meningeal artery embolization (MMAE) has emerged as an adjunct or alternative to surgery, aiming to reduce CSDH recurrence by targeting the vascular supply of the hematoma membranes.

Systematic review and meta-analysis included 17 studies (1814 patients; 939 MMAE+S, 1440 S), comprising randomized trials, matched, and unmatched cohorts, with a mean follow-up of 3 months.

Baseline comparability between MMAE+S and surgery-alone groups was achieved except for higher antithrombotic use in the MMAE+S group (34.9% vs 22.4%).

Recurrence rates were significantly lower in the MMAE+S group compared to surgery alone (4.7% vs 17.7%; relative risk [RR] 0.31, P < .01), a benefit confirmed in randomized and matched studies.

Radiological outcomes (postoperative hematoma thickness, volume, and midline shift) were all significantly reduced in the MMAE+S group.

Functional outcomes, complications, mortality, and hospital stay were similar between groups, indicating no increased risk with adjunctive MMAE.

Timing of embolization affected outcomes: postoperative MMAE was associated with lower recurrence, while preoperative MMAE did not show significant benefit.

Embolic agent selection mattered: liquid embolic agents (e.g., Onyx, Squid) led to better outcomes than particles, with recurrence reduction seen only with liquid agents.

Antithrombotic use, a known risk factor for recurrence, was higher in the MMAE+S group, yet recurrence rates remained lower, suggesting a robust effect of adjunctive MMAE.

Surgical technique variability (burr-hole craniostomy, craniotomy, twist-drill) existed across studies, potentially influencing heterogeneity in outcomes.

Complication rates were low and comparable between groups; most complications were minor, and serious adverse events were rare.

Length of hospital stay did not differ significantly between groups, though some previous studies suggested longer stays with MMAE+S, possibly due to worse initial clinical status.

Cost-effectiveness may favor MMAE+S in the long term, as reduced recurrence and reoperation rates can offset higher initial costs.

Ongoing clinical trials (e.g., CHESS, MEMBRANE, EMPROTECT) are expected to clarify optimal timing, patient selection, and cost-effectiveness of adjunctive MMAE.

Limitations include heterogeneity in surgical and embolization techniques, retrospective study designs, and reliance on aggregate rather than individual patient data.

Areas for future research include optimal timing and materials for MMAE, patient selection, and cost-benefit analyses.

Conclusion

Adjunctive MMAE with surgical evacuation significantly reduces CSDH recurrence and improves radiological outcomes without increasing complications or mortality, supporting its use in high-risk patients.

Posted on

Long-Term Outcomes of Surgical Clipping of Woven EndoBridge-Eligible Middle Cerebral Artery Bifurcation Aneurysms

Operative Neurosurgery 30:18–25, 2026

This clinical study evaluates long-term outcomes of microsurgical clipping for middle cerebral artery (MCA) wide-neck bifurcation aneurysms that meet radiographic criteria for treatment with the Woven EndoBridge (WEB) device. Using a retrospective review of a prospectively maintained registry, the authors compare functional outcomes, complication rates, recurrence, and retreatment against published WEB and clipping cohorts.

Results show high surgical efficacy: 99% treatment success, 94.1% of unruptured cases achieving final mRS ≤2, a 4.9% morbidity rate, and 0% mortality, with lower retreatment and higher complete occlusion rates than reported WEB series. The authors conclude microsurgical clipping remains a reliable option for MCA WNBAs and recommend location-specific subgroup analyses in future WEB studies.

Microsurgical Clipping Outcomes: Surgical clipping of WEB-eligible middle cerebral artery (MCA) wide-necked bifurcation aneurysms (WNBAs) achieved a 99% treatment success rate, 4.9% morbidity, 0% mortality, and 94.1% good functional outcomes (mRS ≤2) in unruptured cases, with low recurrence and retreatment rates.

Comparison to WEB Device: Clipping resulted in higher complete occlusion rates, lower retreatment rates, and lower thromboembolic complication rates compared to endovascular treatment with the Woven EndoBridge (WEB) device for MCA WNBAs.

Functional Outcomes: Both ruptured and unruptured aneurysms treated surgically showed excellent or improved functional status at follow-up, with 91.8% of unruptured and 94.1% of ruptured cases experiencing stable or improved mRS scores.

Complication Profile: Thromboembolic complications occurred in 5.9% of unruptured cases, with permanent neurological deficits in 4.9% and no surgical mortality; intraoperative rupture was rare (2.0%).

Limitations of WEB Evidence: Most WEB studies pooled multiple aneurysm locations, making it difficult to assess location-specific efficacy; at the MCA, WEB showed higher retreatment and thromboembolic rates than clipping, and lower rates of complete occlusion.

Treatment Selection: MCA aneurysms are often suitable for surgical clipping due to their accessible location and favorable anatomy, especially at experienced centers, supporting a “clip-first” approach for many MCA WNBAs.

Study Limitations: Findings are based on a retrospective, single-center cohort at a high-volume academic institution, limiting generalizability and direct comparison to randomized or multicenter WEB trials.

Clinical Recommendation: Both clipping and WEB are effective for MCA WNBAs, but surgical clipping may offer superior durability and occlusion; treatment choice should be individualized through shared decision-making, not solely based on minimally invasive appeal.

Posted on

Artificial intelligence–based deep learning model for evaluating procedural consistency in microvascular anastomosis

J Neurosurg 144:1–10, 2026

This study presents an LSTM-based deep learning model that objectively evaluates microvascular anastomosis performance by predicting hand-motion trajectories from MediaPipe-derived hand landmarks. It quantifies consistency using Kullback-Leibler divergence and validates complementary metrics—economy and flow of motion—comparing two expert neurosurgeons (repeat sessions) and one trainee in simulated end-to-side anastomoses.

Results show low KL divergence for experts versus higher divergence for the trainee, reflecting greater consistency and efficiency. The authors discuss methodology, model architecture choices, limitations in generalizability, and potential integration into microsurgical training workflows for objective skill assessment.

Deep Learning Model: An LSTM-based neural network was developed to objectively assess consistency and precision in microvascular anastomosis by predicting and comparing suturing hand movements using video-based hand landmark tracking, eliminating the need for physical sensors.

Hand Tracking Technology: The model utilized MediaPipe Hand Landmarker, a CNN-based system that detects 21 hand landmarks from standard video, enabling detailed, sensor-free motion analysis during microsurgical simulation.

Performance Metrics: Three primary metrics were used: Kullback-Leibler (KL) divergence for consistency, economy of motion (mean Euclidean distance of hand movement), and flow of motion (median time per suture), providing quantitative, objective evaluation of surgical skill.

Experimental Setup: Two expert neurosurgeons performed microanastomosis simulations (interrupted and continuous suturing) in two sessions one year apart, and a trainee performed the same task for comparison; all sessions were recorded and analyzed using the AI pipeline.

Results and Interpretation: Experts showed low KL divergence (high consistency) and efficient, rhythmic motion, while the trainee had higher KL divergence, longer suture intervals, and more variable motion, reflecting less developed skill.

Model Application: The approach enables rapid, automated assessment of multiple trainees using standard video equipment, supporting objective tracking of skill progression and facilitating feedback in training environments.

Model Rationale: LSTM architecture was chosen for its ability to model long-term temporal dependencies in sequential hand movement data, making it suitable for predicting surgical motion patterns over extended timeframes.

Limitations and Future Directions: Current findings are based on a small sample of experts and one trainee in a simulated environment; broader validation, metric standardization (especially for KL divergence), and extension to real operative settings are needed for generalizability.

Posted on

Guidelines for the Diagnosis and Clinical Management of Cavernous Malformations of the Brain and Spinal Cord

Neurosurgery 98:3–22, 2026

These guidelines present updated, evidence-based recommendations for diagnosing and managing cavernous malformations (CMs) of the brain and spinal cord, produced by an expert multidisciplinary panel convened by the Alliance to Cure Cavernous Malformation. The document summarizes systematic literature review methods, evidence ratings, and 53 consensus recommendations across epidemiology, genetics, imaging, neurosurgery, and neurology.

Key clinical guidance addresses diagnostic MRI protocols, genetic testing for familial CM (KRIT1/CCM2/PDCD10), surgical/radiosurgical indications including pediatric and geriatric considerations, seizure and headache management, and lifestyle and medication factors potentially affecting hemorrhage risk. Recommendations highlight evidence limitations and prioritize further research.

Diagnosis: MRI with susceptibility-weighted sequences is the gold standard for diagnosing cavernous malformations (CMs); CT may be used in emergencies, but MRI is preferred for follow-up and detailed assessment.

Genetic Testing: Genetic testing for KRIT1 (CCM1), CCM2, and PDCD10 (CCM3) is recommended for individuals with multiple CMs, a family history, or suspected familial CM (FCM); founder mutations exist in certain populations.

Hemorrhage Risk: Annual risk of symptomatic intracranial hemorrhage (ICH) from CMs ranges from 0.7% to 7.5%, with higher risk for recurrent bleeds and in familial cases, especially with CCM3 mutations.

Surgical Management: Surgery is generally reserved for symptomatic, accessible CMs or those causing drug-resistant epilepsy; conservative management is preferred for asymptomatic or deep/eloquent area lesions unless recurrent bleeds occur.

Medical Management: Antiseizure medication is recommended after a first CM-related seizure; standard migraine therapy applies for nonhemorrhagic CMs, and nonaspirin NSAIDs can be used cautiously.

Pregnancy: Pregnancy does not increase the risk of CM hemorrhage compared to nonpregnant states; MRI without contrast is advised for new neurological symptoms during pregnancy.

Medication Risks: Antithrombotic agents (e.g., aspirin) do not increase and may actually lower CM hemorrhage risk, while female hormones may increase risk; thrombolytic use remains controversial and should be considered on a case-by-case basis.

Lifestyle and Emerging Therapies: Vitamin D supplementation, aerobic activity, and a diet low in processed foods are reasonable lifestyle recommendations; propranolol and statins show potential but lack definitive evidence for reducing hemorrhage risk.

Proudly powered by WordPress